Pin your most used calculators here by clicking the star in the dropdown.
LIPI Score (Lung Immune)
Clinical Context & Background
The Lung Immune Prognostic Index (LIPI) stratifies outcomes in patients with metastatic Non-Small Cell Lung Cancer (NSCLC) treated with immune checkpoint inhibitors (PD-1/PD-L1 inhibitors). It uses derived NLR (dNLR) and LDH.
Formula Logic
Risk factors: dNLR > 3 and LDH > ULN.Reference Data
| Risk Group | Factors | Outcomes |
|---|---|---|
| Good | 0 factors | Best PFS and OS |
| Intermediate | 1 factor | Intermediate outcomes |
| Poor | 2 factors | Worst PFS and OS |
Evidence-based oncology decision support. Verify with clinical guidelines.